These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 22349069)

  • 1. The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis.
    Nicolson CH; Stirling RG; Borg BM; Button BM; Wilson JW; Holland AE
    Respir Med; 2012 May; 106(5):661-7. PubMed ID: 22349069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
    Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
    Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nebulised 7% hypertonic saline improves lung function and quality of life in bronchiectasis.
    Kellett F; Robert NM
    Respir Med; 2011 Dec; 105(12):1831-5. PubMed ID: 22018993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial.
    Wong C; Jayaram L; Karalus N; Eaton T; Tong C; Hockey H; Milne D; Fergusson W; Tuffery C; Sexton P; Storey L; Ashton T
    Lancet; 2012 Aug; 380(9842):660-7. PubMed ID: 22901887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inhalation of hypertonic saline: a promising therapy in bronchiectasis].
    Koskela H; Purokivi M
    Duodecim; 2011; 127(24):2653-9. PubMed ID: 22320108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial.
    Altenburg J; de Graaff CS; Stienstra Y; Sloos JH; van Haren EH; Koppers RJ; van der Werf TS; Boersma WG
    JAMA; 2013 Mar; 309(12):1251-9. PubMed ID: 23532241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
    Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
    Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores.
    Quittner AL; O'Donnell AE; Salathe MA; Lewis SA; Li X; Montgomery AB; O'Riordan TG; Barker AF
    Thorax; 2015 Jan; 70(1):12-20. PubMed ID: 25323621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adults with cystic fibrosis prefer hypertonic saline before or during airway clearance techniques: a randomised crossover trial.
    Dentice RL; Elkins MR; Bye PT
    J Physiother; 2012; 58(1):33-40. PubMed ID: 22341380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertonic saline improves the LCI in paediatric patients with CF with normal lung function.
    Amin R; Subbarao P; Jabar A; Balkovec S; Jensen R; Kerrigan S; Gustafsson P; Ratjen F
    Thorax; 2010 May; 65(5):379-83. PubMed ID: 20435858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled steroids improve quality of life in patients with steady-state bronchiectasis.
    Martínez-García MA; Perpiñá-Tordera M; Román-Sánchez P; Soler-Cataluña JJ
    Respir Med; 2006 Sep; 100(9):1623-32. PubMed ID: 16434174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials.
    Barker AF; O'Donnell AE; Flume P; Thompson PJ; Ruzi JD; de Gracia J; Boersma WG; De Soyza A; Shao L; Zhang J; Haas L; Lewis SA; Leitzinger S; Montgomery AB; McKevitt MT; Gossage D; Quittner AL; O'Riordan TG
    Lancet Respir Med; 2014 Sep; 2(9):738-49. PubMed ID: 25154045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.
    Rosenfeld M; Ratjen F; Brumback L; Daniel S; Rowbotham R; McNamara S; Johnson R; Kronmal R; Davis SD;
    JAMA; 2012 Jun; 307(21):2269-77. PubMed ID: 22610452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of hypertonic saline inhalation combined with exercise training in patients with chronic obstructive pulmonary disease: a randomized trial.
    Valderramas SR; Atallah AN
    Respir Care; 2009 Mar; 54(3):327-33. PubMed ID: 19245725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventive Inhalation of Hypertonic Saline in Infants with Cystic Fibrosis (PRESIS). A Randomized, Double-Blind, Controlled Study.
    Stahl M; Wielpütz MO; Ricklefs I; Dopfer C; Barth S; Schlegtendal A; Graeber SY; Sommerburg O; Diekmann G; Hüsing J; Koerner-Rettberg C; Nährlich L; Dittrich AM; Kopp MV; Mall MA
    Am J Respir Crit Care Med; 2019 May; 199(10):1238-1248. PubMed ID: 30409023
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.
    Elkins MR; Robinson M; Rose BR; Harbour C; Moriarty CP; Marks GB; Belousova EG; Xuan W; Bye PT;
    N Engl J Med; 2006 Jan; 354(3):229-40. PubMed ID: 16421364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled hypertonic saline as a therapy for cystic fibrosis.
    Elkins MR; Bye PT
    Curr Opin Pulm Med; 2006 Nov; 12(6):445-52. PubMed ID: 17053496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.